We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Basilea Pharmaceutica Ag | LSE:0QNA | London | Ordinary Share | CH0011432447 | BASILEA PHARMACEUTICA ORD SHS |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
45.05 | 47.35 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 150.28M | 10.45M | 0.8708 | 51.05 | 533.49M |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
16:13:36 | O | 1 | 40.40 | CHF |
Date | Time | Source | Headline |
---|---|---|---|
03/5/2024 | 06:15 | UKREG | Basilea reports presentation of new data for ceftobiprole (Zevtera®) at.. |
03/5/2024 | 06:15 | UKREG | Basilea berichtet über Präsentation neuer Daten zu Ceftobiprol (Zevtera®).. |
24/4/2024 | 17:00 | UKREG | Basilea shareholders approve all proposals of the board of directors at the.. |
24/4/2024 | 17:00 | UKREG | Basilea-Aktionäre genehmigen an der Generalversammlung alle Anträge des.. |
09/4/2024 | 06:15 | UKREG | Basilea awarded CARB-X grant to develop recently acquired novel class of.. |
09/4/2024 | 06:15 | UKREG | Basilea erhält CARB-X-Förderung für die Entwicklung einer kürzlich.. |
04/4/2024 | 06:15 | UKREG | Basilea gibt Erhalt der US-FDA-Zulassung für Antibiotikum ZEVTERA®.. |
04/4/2024 | 06:15 | UKREG | Basilea announces US FDA approval of antibiotic ZEVTERA® (ceftobiprole.. |
11/3/2024 | 06:15 | UKREG | Anhaltend gute Cresemba® (Isavuconazol)-Umsätze in der Region Asien-Pazifik.. |
11/3/2024 | 06:15 | UKREG | Continued strong Cresemba® (isavuconazole) sales performance in Asia.. |
Basilea Pharmaceutica (0QNA) Share Charts1 Year Basilea Pharmaceutica Chart |
|
1 Month Basilea Pharmaceutica Chart |
Intraday Basilea Pharmaceutica Chart |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|---|---|---|---|
2024-05-03 15:13:37 | 40.40 | 1 | 0.00 | O |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions